Related Experiment Video
Updated: Feb 4, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Transcatheter aortic valve replacement in low risk patients
Lucia Junquera1, Alfredo Ferreira-Neto1, Leonardo Guimaraes1
1Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
Transcatheter aortic valve replacement (TAVR) is becoming a preferred treatment for aortic stenosis, showing comparable results to surgery in intermediate-risk patients. Ongoing trials will determine its efficacy in low-risk individuals, potentially making TAVR the standard of care.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Technology
Background:
- Transcatheter aortic valve replacement (TAVR) has rapidly advanced, expanding from high-risk to lower-risk patient populations.
- Surgical aortic valve replacement (SAVR) has been the traditional treatment for severe aortic stenosis.
Purpose of the Study:
- To evaluate the expanding role and efficacy of TAVR in various patient risk groups, including low-risk individuals.
- To assess TAVR's comparability to SAVR and its potential to become the primary treatment for aortic stenosis.
Main Methods:
- Review of TAVR technology refinement and clinical experience.
- Analysis of observational, propensity-matched, and randomized trial data comparing TAVR and SAVR outcomes.
- Monitoring of ongoing randomized trials in low-risk patients.
Main Results:
- TAVR demonstrates results comparable to SAVR in intermediate-risk patients.
- Preliminary studies show promising outcomes for TAVR in low-risk populations.
- A small trial indicated TAVR's non-inferiority to SAVR for early and late outcomes up to six years.
Conclusions:
- TAVR is a viable and increasingly preferred option for severe aortic stenosis, even in lower-risk patients.
- Further research and ongoing trials are crucial to establish TAVR as the default treatment.
- Addressing valve durability and complications like conduction disturbances is key for TAVR's widespread adoption.
Related Concept Videos
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Relative Risk
Continuous Renal Replacement Therapy
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Mitral Valve Prolapse I: Introduction
Aortic Regurgitation I: Introduction

